154 | CLINICAL IMPACT OF UNTARGETED BASELINE PLASMA METABOLOMICS IN NEWLY DIAGNOSED DIFFUSE LARGE B CELL LYMPHOMAR. Dondolin, Riccardo Moia, Denise Marradi et al.|Hematological Oncology|2025Cited by 0
Clinical impact of untargeted baseline plasma metabolomics in newly diagnosed diffuse large B-cell lymphomaRiccardo Dondolin, Riccardo Moia, Lodovico Terzi di Bergamo et al.|Blood|2025Cited by 0